<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="7735" OLDID="13256" TOPICS="YES">
<DATE>20-MAR-1987 11:11:32.22</DATE>
<TOPICS><D>earn</D></TOPICS>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f1243 reute
r f BC-SPI-PHARMACEUTICALS-I   03-20 0050</UNKNOWN>
<TEXT> 
<TITLE>SPI PHARMACEUTICALS INC &lt;SPIP&gt; 1ST QTR OPER NET</TITLE>
<DATELINE>    COSTA MESA, Calif., March 20 - </DATELINE><BODY>Qtr ended Feb 28
    Oper shr 31 cts vs 14 cts
    Oper net 3,203,000 vs 1,357,000
    Revs 13.0 mln vs 15.6 mln
    Note: Oper data does not include year ago extraordinary
gain of 821,000 dlrs, or eight cts per shr.
 Reuter
 </BODY></TEXT>
</REUTERS>